Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds

Prospective, Multicentre, Not Controlled Clinical Study to Investigate Efficacy and Tolerability of the Hyaluronic Acid Filler IMD1 Basic After Single Bilateral Injection for Correction of Nasolabial Folds (NLF)

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00429520

Enrollment

114

Registered

2007-01-31

Start date

2005-12-31

Completion date

2006-12-31

Last updated

2008-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasolabial Folds

Brief summary

Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.

Interventions

DRUGHyaluronic acid filler/IMD1 basic

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

30 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* main inclusion criteria: severity rating scale grade 3 or 4

Exclusion criteria

* main exclusion criterion: other nasolabial fold corrections within 6 months prior to study entry

Design outcomes

Primary

Measure	Time frame
Severity rating scale assessed by independent rater	—

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026